In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 8,689 | 8,645 | 7,598 | 7,169 | 7,715 |
| Operating Income | -8,689 | -8,645 | -7,598 | -7,169 | -7,715 |
| Other Income | 60 | 83 | 0 | 0 | 0 |
| Pre-tax Income | -8,629 | -8,562 | -7,598 | -7,169 | -7,715 |
| Net Income Continuous | -8,629 | -8,562 | -7,598 | -7,169 | -7,715 |
| Net Income | $-8,629 | $-8,562 | $-7,598 | $-7,169 | $-7,715 |
| EPS Basic Total Ops | -5.51 | -6.01 | -6.01 | -6.91 | -8.11 |
| EPS Basic Continuous Ops | -5.51 | -5.94 | -6.07 | -6.82 | -8.14 |
| EPS Diluted Total Ops | -5.51 | -6.01 | -6.01 | -6.91 | -8.11 |
| EPS Diluted Continuous Ops | -5.51 | -5.94 | -6.07 | -6.82 | -8.14 |
| EPS Diluted Before Non-Recurring Items | -5.71 | -6.01 | -6.31 | N/A | N/A |
| EBITDA(a) | $-8,058 | $-8,013 | $-6,971 | $-6,522 | $-7,078 |